Kidney Transplantation Clinical Trials

554 clinical trials for Kidney Transplantation across international registries, including 43 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients — RECRUITING · PHASE2
• Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET) — RECRUITING · PHASE1
• Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD — RECRUITING · PHASE1
• TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation — RECRUITING · NA
• Kidney Transplant Improvement Through New Exercise Training to Increase Capacity — RECRUITING · NA
• Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel — RECRUITING · NA
• Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients — RECRUITING · PHASE1
• REgulatory T Cell Therapy to Achieve Immunosuppression REduction — RECRUITING · PHASE2
• Shingrix in Renal Transplant Recipients — RECRUITING · PHASE3
• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD — RECRUITING · PHASE1
• Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. — RECRUITING · PHASE4
• Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation. — RECRUITING · NA
• The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients — RECRUITING · PHASE1
• A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, RANDOMIZED PHASE 2 TRIAL EVALUATING THE EFFICACY AND SAFETY OF FELZARTAMAB IN RECIPIENTS OF KIDNEY TRANSPLANTS WITH LATE ISOLATED MICROVASCULAR INFLAMMATION (MVI) - (TRANSPIRE0 — RECRUITING · PHASE2
• Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing — RECRUITING
• Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension — RECRUITING · NA
• Screening for subclinical antibody mediated rejection and efficacy of belatacept in the context of de novo donor specific antibody after kidney transplantation / BEL-AMR — RECRUITING · PHASE3
• A PHASE 2B, NON-RANDOMIZED, CONTROLLED, OPEN-LABEL, EXTENSION STUDY TO EVALUATE THE PERSISTENCE OF IMMUNE RESPONSE OF THE ADJUVANTED RSVPREF3 VACCINE AND THE SAFETY AND IMMUNOGENICITY FOLLOWING REVACCINATION IN LUNG AND KIDNEY TRANSPLANT RECIPIENTS (¿18 YEARS OF AGE) — RECRUITING · PHASE2
• Prehabilitation for Kidney Transplant Candidates — RECRUITING · NA
• SEMAGLUTIDE FOR THE PREVENTION OF POST-TRANSPLANT DIABETES MELLITUS IN KIDNEY TRANSPLANT RECIPIENTS — RECRUITING
• Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation — RECRUITING · PHASE2
• A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RAVULIZUMAB ADMINISTERED INTRAVENOUSLY IN ADULT PARTICIPANTS AT HIGH RISK OF DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION — RECRUITING · PHASE3
• BIOmarkers Before and After Kidney Transplantation — RECRUITING
• Prevention of Incisional Hernia After Renal Transplantation — RECRUITING · NA
• Continuous Glucose Monitoring (CGM) After Kidney Transplantation — RECRUITING
• Ex Vivo Normothermic Perfusion in Kidney Transplantation. — RECRUITING · NA
• Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) — RECRUITING · NA
• Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation — RECRUITING
• Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch — RECRUITING · PHASE4
• EVALUATION OF THIOSULFATE IN END STAGE RENAL DISEASE AND KIDNEY TRANSPLANTATION — RECRUITING
• Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates — RECRUITING · NA
• Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity — RECRUITING · NA
• A PHASE 2B, RANDOMIZED, CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE IMMUNE RESPONSE AND SAFETY OF THE RSVPREF3 OA INVESTIGATIONAL VACCINE IN ADULTS (¿50 YEARS OF AGE) WHEN ADMINISTERED TO LUNG AND RENAL TRANSPLANT RECIPIENTS COMPARING 1 VERSUS 2 DOSES AND COMPARED TO HEALTHY CONTROLS (¿50 YEARS OF AGE) RECEIVING 1 DOSE — RECRUITING · PHASE2
• BESTOW-EXT: A PHASE 2, MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND EFFICACY OF TEGOPRUBART IN KIDNEY TRANSPLANT RECIPIENTS — RECRUITING · PHASE2
• THE EFFICACY, MECHANISM & SAFETY OF SODIUM GLUCOSE CO-TRANSPORTER-2 INHIBITOR & GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST COMBINATION THERAPY IN KIDNEY TRANSPLANT RECIPIENTS: THE HALLMARK STUDY — RECRUITING
• BESTOW: A PHASE 2, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TEGOPRUBART IN PATIENTS UNDERGOING KIDNEY TRANSPLANTATION — RECRUITING · PHASE2
• A MULTI-COHORT, RANDOMIZED, PHASE 2, OPEN-LABEL STUDY TO ASSESS THE PRELIMINARY EFFICACY, SAFETY, AND PHARMACOKINETICS OF BIVV020 FOR PREVENTION AND TREATMENT OF ANTIBODY-MEDIATED REJECTION IN ADULT KIDNEY TRANSPLANT RECIPIENTS — RECRUITING · PHASE2
• Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant Patients — RECRUITING
• A PHASE 1B, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF AT-1501 IN PATIENTS UNDERGOING KIDNEY TRANSPLANT — RECRUITING · PHASE1
• Predicting the impact of the gut microbiome on immunosuppressive drug metabolism in kidney transplant patients — RECRUITING
• EFFICACY, MECHANISMS AND SAFETY OF SGLT2 INHIBITORS IN KIDNEY TRANSPLANT RECIPIENTS: "INFINITI" — RECRUITING
• A PHASE 3 PROSPECTIVE, RANDOMIZED, MULTI-CENTER, OPEN-LABEL, CONTROLLED TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CELLULAR IMMUNOTHERAPY WITH MDR-101 FOR INDUCTION OF IMMUNE TOLERANCE IN RECIPIENTS OF HLA-MATCHED, LIVING DONOR KIDNEY TRANSPLANTS — RECRUITING · PHASE3
• Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation — RECRUITING
• Testing the ability to reduce immunosuppression in older renal transplant recipients — TERMINATED
• Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of mofetil mycophenolate — COMPLETED · PHASE2
• The immune response during treatment with belatacept after kidney transplantation. — ACTIVE_NOT_RECRUITING · PHASE4
• Tacrolimus monotherapy for low risk kidney transplant recipients. — ACTIVE_NOT_RECRUITING · PHASE2
• A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMBINATION WITH MMF (CELLCEPT) AND STEROIDS IN PATIENTS UNDERGOING KIDNEY TRANSPLANTATION — COMPLETED · PHASE3
• Early (Postoperative Day 3) Versus Standard (Postoperative Day 6) Urethral Catheter Removal After Living Donor Kidney Transplantation — ACTIVE_NOT_RECRUITING · NA
• Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search